RFPL4AL1
Ret finger protein-like 4A-like protein 1
Also known as: RFAL1_HUMAN, RNF210B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- F8VTS6
- Gene
- RFPL4AL1
- Ensembl
- ENSG00000229292
- Chromosome
- 19
- Canonical length
- 287 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Centrosome,Cytosol
OverviewNCBI Gene
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
287 residues, UniProt reviewed canonical sequence.
>F8VTS6|RFPL4AL1
1 MAEHFKQIIR CPVCLKDLEE AVQLKCGYAC CLQCLNSLQK EPDGEGLLCR FCSVVSQKDD
61 IKPKYKLRAL VSIIKELEPK LKSVLTMNPR MRKFQVDMTF DVDTANNYLI ISEDLRSFRS
121 GDLSQNRKEQ AERFDTALCV LGTPRFTSGR HYWEVDVGTS QVWDVGVCKE SVNRQGKIEL
181 SSEHGFLTVG CREGKVFAAS TVPMTPLWVS PQLHRVGIFL DVGMRSIAFY NVSDGCHINT
241 FIEIPVCEPW RPFFAHKRGS QDDQSILSIC SVINPSTASA PVSSEGKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RFPL4AL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 0.6 nTPM
Expression across tissuesHPA
Tissue
- liver: 0.6 nTPM
- spleen: 0.3 nTPM
- epididymis: 0.2 nTPM
- testis: 0.2 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- undifferentiated spermatogonia: 0.8 nCPM
- cdc: 0.7 nCPM
- early spermatids: 0.6 nCPM
- hepatocytes: 0.4 nCPM
- peritubular myoid cells: 0.3 nCPM
- sertoli cells: 0.3 nCPM
Immune cell
- classical monocyte: 1.9 nTPM
- myeloid DC: 0.8 nTPM
- total PBMC: 0.7 nTPM
- intermediate monocyte: 0.3 nTPM
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- medulla oblongata: 0.6 nTPM
- midbrain: 0.4 nTPM
- cerebral cortex: 0.3 nTPM
- spinal cord: 0.3 nTPM
- basal ganglia: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.47
- gnomAD pLI
- 0.22
- gnomAD missense Z
- 1.1
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, RING-type
- B30.2/SPRY domain
- SPRY domain
- Butyrophylin-like, SPRY domain
- SPRY-associated
- Zinc finger, RING/FYVE/PHD-type
- Concanavalin A-like lectin/glucanase domain superfamily
- RDM domain, Ret finger protein-like
- Ret finger protein-like, SPRY/PRY domain
- B30.2/SPRY domain superfamily
- Tripartite motif-containing
- SPRY domain
- RFPL defining motif (RDM)
- SPRY-associated domain
- zinc finger of C3HC4-type, RING
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RFPL4AL1 as an antibody target. Whether an autoantibody or antibody against RFPL4AL1 could matter depends on whether native RFPL4AL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RFPL4AL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RFPL4AL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...